Oscar Health (OSCR) CLO awarded 67,424 RSUs and sells 18,710 shares

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Oscar Health, Inc. Chief Legal Officer Adam McAnaney reported two equity transactions in Class A common stock. He received a grant of 67,424 restricted stock units at no cost, which will vest quarterly in 12 equal installments beginning on June 1, 2026, contingent on continued service.

On the same date, he sold 18,710 shares in an open-market transaction at a weighted average price of $13.39 per share, with individual trade prices ranging from $13.00 to $13.85. The sale was executed under a pre-established Rule 10b5-1 instruction letter to cover tax withholding obligations from earlier equity awards. Following these transactions, he directly owns 227,955 shares of Class A common stock, including shares underlying restricted stock units that will be issued upon vesting.

Insider Trade Summary

Net Seller: 18,710 shares ($250,527)

Net Sell 2 txns

Insider McAnaney Adam

Role Chief Legal Officer

Sold 18,710 shs ($251K)

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	67,424	$0.00	--
Sale	Class A Common Stock	18,710	$13.39	$251K

Holdings After Transaction: Class A Common Stock — 246,665 shares (Direct)

Footnotes (1)

The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to the reporting person's continuous service through each vesting date. Includes shares to be issued in connection with the vesting of one or more restricted stock units. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Form 4 Insider Transactions: What Each Field Means →

03/04/2026 - 04:18 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McAnaney Adam

(Last)

(First)

(Middle)

75 VARICK STREET, 5TH FLOOR

(Street)

NEW YORK

10013

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	03/02/2026		A		67,424⁽¹⁾	A	$0	246,665⁽²⁾	D
Class A Common Stock	03/02/2026		S		18,710⁽³⁾	D	$13.39⁽⁴⁾	227,955	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to the reporting person's continuous service through each vesting date.

2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

3. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Remarks:

	/s/ Melissa Curtin, Attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Oscar Health (OSCR) report for Adam McAnaney?

Oscar Health reported that Chief Legal Officer Adam McAnaney received a grant of 67,424 restricted stock units and sold 18,710 shares of Class A common stock. The grant was at no cost, while the sale was executed in the open market under a Rule 10b5-1 plan.

How many Oscar Health (OSCR) shares did Adam McAnaney sell and at what price?

Adam McAnaney sold 18,710 shares of Oscar Health Class A common stock at a weighted average price of $13.39 per share. Individual trades occurred between $13.00 and $13.85, and he has committed to provide detailed price breakdowns upon request.

What equity award did Oscar Health (OSCR) grant to its Chief Legal Officer?

Oscar Health granted Chief Legal Officer Adam McAnaney 67,424 restricted stock units of Class A common stock at no purchase price. These units will vest in 12 equal quarterly installments starting June 1, 2026, conditioned on his continued service through each vesting date.

Why did Adam McAnaney’s Oscar Health (OSCR) Rule 10b5-1 sale occur?

The sale of 18,710 Oscar Health shares by Adam McAnaney was made under a Rule 10b5-1 instruction letter. It was specifically arranged to satisfy his tax withholding obligations arising from the vesting of previously granted equity awards, rather than a discretionary open-market sale.

How many Oscar Health (OSCR) shares does Adam McAnaney own after these transactions?

After the reported grant and sale, Adam McAnaney directly owns 227,955 shares of Oscar Health Class A common stock. This figure includes shares that will be issued upon the vesting of one or more restricted stock unit awards described in the filing.

When will Adam McAnaney’s new Oscar Health (OSCR) restricted stock units vest?

The newly granted 67,424 restricted stock units will vest quarterly over three years. Vesting occurs in 12 equal installments beginning June 1, 2026, and each installment requires Adam McAnaney to remain in continuous service with Oscar Health through the applicable vesting date.